2025 annual financial data

Rani Therapeutics Holdings 2025 Operating margin

Rani Therapeutics Holdings 2025 operating margin with verified reported values.

Direct answer

Operating margin was -2,345.99%.

Operating income was -38,310,000 USD and net income was -29,673,000 USD.
Operating cash flow was -18,714,000 USD.

Get free Rani Therapeutics Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,633,000 USD
Operating income
-38,310,000 USD
Net income
-29,673,000 USD
Operating cash flow
-18,714,000 USD